Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lysine (K)-specific methyltransferase 2A | Starlite/ChEMBL | No references |
Mus musculus | heat shock factor 1 | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Homo sapiens | multiple endocrine neoplasia I | No references | |
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | expressed protein | Ferritin light chain | 175 aa | 146 aa | 30.1 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 142 aa | 29.6 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 43.9 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 44.4 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Echinococcus granulosus | expressed protein | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma japonicum | Ferritin, putative | Ferritin light chain | 175 aa | 144 aa | 24.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | hexokinase | 0.0251 | 0.2951 | 0.2951 |
Leishmania major | hexokinase, putative | 0.0251 | 0.2951 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | bacterioferritin/cytochrome b1 | 0.001 | 0.0033 | 0.5 |
Schistosoma mansoni | ferritin | 0.001 | 0.0033 | 0.0033 |
Onchocerca volvulus | 0.0251 | 0.2951 | 1 | |
Echinococcus multilocularis | hexokinase | 0.0251 | 0.2951 | 0.2951 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0039 | 0.0039 |
Echinococcus multilocularis | mixed lineage leukemia protein mll | 0.0009 | 0.0013 | 0.0013 |
Loa Loa (eye worm) | hexokinase | 0.0251 | 0.2951 | 1 |
Brugia malayi | Hexokinase family protein | 0.0251 | 0.2951 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0009 | 0.0013 | 0.0013 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.0353 | 0.0353 |
Schistosoma mansoni | apoferritin-2 | 0.001 | 0.0033 | 0.0033 |
Schistosoma mansoni | ferritin light chain | 0.001 | 0.0033 | 0.0033 |
Onchocerca volvulus | Heat shock factor protein 2 homolog | 0.012 | 0.1359 | 0.3928 |
Trypanosoma cruzi | hexokinase, putative | 0.0251 | 0.2951 | 0.5 |
Loa Loa (eye worm) | hexokinase type II | 0.0251 | 0.2951 | 1 |
Mycobacterium tuberculosis | Bacterioferritin BfrB | 0.001 | 0.0033 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.0876 | 0.2875 |
Brugia malayi | HSF-type DNA-binding domain containing protein | 0.012 | 0.1359 | 0.4536 |
Echinococcus granulosus | hexokinase | 0.0251 | 0.2951 | 0.2951 |
Schistosoma mansoni | ferritin | 0.001 | 0.0033 | 0.0033 |
Brugia malayi | Hexokinase family protein | 0.0158 | 0.1817 | 0.611 |
Echinococcus multilocularis | cpg binding protein | 0.0037 | 0.0353 | 0.0353 |
Mycobacterium tuberculosis | Probable bacterioferritin BfrA | 0.001 | 0.0033 | 0.5 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0013 | 0.0013 |
Mycobacterium ulcerans | bacterioferritin BfrB | 0.001 | 0.0033 | 0.5 |
Entamoeba histolytica | heat shock transcription factor, putative | 0.012 | 0.1359 | 0.4605 |
Plasmodium vivax | hexokinase, putative | 0.0251 | 0.2951 | 0.5 |
Echinococcus multilocularis | hexokinase | 0.0251 | 0.2951 | 0.2951 |
Leishmania major | hexokinase, putative | 0.0251 | 0.2951 | 0.5 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0035 | 0.0329 | 0.0996 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 1 | 1 |
Loa Loa (eye worm) | hexokinase | 0.0158 | 0.1817 | 0.6107 |
Echinococcus granulosus | mixed lineage leukemia protein mll | 0.0009 | 0.0013 | 0.0013 |
Loa Loa (eye worm) | hexokinase | 0.0251 | 0.2951 | 1 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0039 | 0.0039 |
Schistosoma mansoni | ferritin | 0.001 | 0.0033 | 0.0033 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.0329 | 0.0329 |
Entamoeba histolytica | heat shock transcription factor, putative | 0.012 | 0.1359 | 0.4605 |
Trypanosoma brucei | hexokinase, putative | 0.0251 | 0.2951 | 0.5 |
Mycobacterium leprae | PROBABLE BACTERIOFERRITIN BFRA | 0.001 | 0.0033 | 0.5 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0074 | 0.08 | 0.08 |
Brugia malayi | Hexokinase family protein | 0.0078 | 0.085 | 0.279 |
Treponema pallidum | hexokinase (hxk) | 0.0251 | 0.2951 | 1 |
Onchocerca volvulus | 0.0251 | 0.2951 | 1 | |
Schistosoma mansoni | hexokinase | 0.0251 | 0.2951 | 0.2951 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.0353 | 0.0353 |
Echinococcus multilocularis | expressed protein | 0.001 | 0.0033 | 0.0033 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.0876 | 0.2875 |
Onchocerca volvulus | 0.0251 | 0.2951 | 1 | |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0013 | 0.0013 |
Mycobacterium ulcerans | bacterioferritin BfrA | 0.001 | 0.0033 | 0.5 |
Brugia malayi | hexokinase type II | 0.008 | 0.0876 | 0.2879 |
Trichomonas vaginalis | ferritin, putative | 0.001 | 0.0033 | 1 |
Echinococcus multilocularis | hexokinase | 0.0251 | 0.2951 | 0.2951 |
Onchocerca volvulus | 0.0158 | 0.1817 | 0.5677 | |
Echinococcus multilocularis | ferritin | 0.001 | 0.0033 | 0.0033 |
Entamoeba histolytica | hexokinase 2 | 0.0251 | 0.2951 | 1 |
Entamoeba histolytica | hexokinase 1 | 0.0251 | 0.2951 | 1 |
Brugia malayi | hexokinase | 0.0251 | 0.2951 | 1 |
Onchocerca volvulus | Hexokinase homolog | 0.0158 | 0.1817 | 0.5677 |
Schistosoma mansoni | ferritin | 0.001 | 0.0033 | 0.0033 |
Entamoeba histolytica | heat shock transcription factor, putative | 0.012 | 0.1359 | 0.4605 |
Loa Loa (eye worm) | hypothetical protein | 0.0171 | 0.1984 | 0.6679 |
Schistosoma mansoni | hypothetical protein | 0.0494 | 0.589 | 0.589 |
Echinococcus multilocularis | dnaJ subfamily B | 0.0494 | 0.589 | 0.589 |
Plasmodium falciparum | hexokinase | 0.0251 | 0.2951 | 0.5 |
Trypanosoma cruzi | hexokinase, putative | 0.0251 | 0.2951 | 0.5 |
Schistosoma mansoni | ferritin light chain | 0.001 | 0.0033 | 0.0033 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.1359 | 0.4533 |
Echinococcus granulosus | ferritin | 0.001 | 0.0033 | 0.0033 |
Brugia malayi | CXXC zinc finger family protein | 0.0035 | 0.0329 | 0.1001 |
Trypanosoma brucei | hexokinase | 0.0251 | 0.2951 | 0.5 |
Echinococcus granulosus | expressed protein | 0.001 | 0.0033 | 0.0033 |
Echinococcus multilocularis | hexokinase type 2 | 0.0251 | 0.2951 | 0.2951 |
Echinococcus granulosus | cpg binding protein | 0.0037 | 0.0353 | 0.0353 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 1 | 1 |
Echinococcus granulosus | dnaJ subfamily B | 0.0494 | 0.589 | 0.589 |
Schistosoma mansoni | apoferritin-2 | 0.001 | 0.0033 | 0.0033 |
Echinococcus granulosus | hexokinase | 0.0251 | 0.2951 | 0.2951 |
Trypanosoma brucei | hexokinase | 0.0251 | 0.2951 | 0.5 |
Loa Loa (eye worm) | hexokinase | 0.0078 | 0.085 | 0.2786 |
Echinococcus granulosus | hexokinase type 2 | 0.0251 | 0.2951 | 0.2951 |
Toxoplasma gondii | hexokinase | 0.0251 | 0.2951 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 15.239 um | PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Confirmation HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). (Class of assay: confirmatory) [Related pubchem assays: 2118 (Project Summary), 2098 (Primary HTS)] | ChEMBL. | No reference |
Potency (functional) | 0.0738 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (binding) | = 3.5481 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | = 8.9125 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 14.1254 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.